Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer
J Okami, K Taniguchi, M Higashiyama, J Maeda, K Oda… - Oncology, 2008 - karger.com
Abstract Background and Objectives: The association between epidermal growth factor
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer
J Okami, K Taniguchi, M Higashiyama… - …, 2007 - pubmed.ncbi.nlm.nih.gov
Background and objectives The association between epidermal growth factor receptor
(EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
(EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung Cancer
J Okami, K Taniguchi, M Higashiyama, J Maeda, K Oda… - Oncology, 2008 - karger.com
Abstract Background and Objectives: The association between epidermal growth factor
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung Cancer.
J Okami, K Taniguchi, M Higashiyama, J Maeda… - …, 2007 - search.ebscohost.com
Abstract Background and Objectives: The association between epidermal growth factor
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
[引用][C] Prognostic factors for Gefitinib-treated postoperative recurrence in non-small cell lung cancer
J OKAMI - Oncology, 2007 - cir.nii.ac.jp
Prognostic factors for Gefitinib-treated postoperative recurrence in non-small cell lung cancer |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung Cancer
J Okami, K Taniguchi, M Higashiyama, J Maeda… - …, 2008 - search.proquest.com
Abstract Background and Objectives: The association between epidermal growth factor
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
receptor (EGFR) mutations and response to EGFR tyrosine kinase inhibitor (TKI) has been …
Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer.
J Okami, K Taniguchi, M Higashiyama, J Maeda, K Oda… - Oncology, 2007 - europepmc.org
Methods EGFR mutations were analyzed in 169 primary lung cancer tissues by RT-PCR and
sequencing of multiple clones. The association between EGFR mutation status and the …
sequencing of multiple clones. The association between EGFR mutation status and the …
[引用][C] Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung Cancer
J OKAMI, K TANIGUCHI, M HIGASHIYAMA… - …, 2007 - pascal-francis.inist.fr
Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung
Cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Cancer CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[引用][C] Prognostic Factors for Gefitinib-Treated Postoperative Recurrence in Non-Small Cell Lung Cancer
J Okami, K Taniguchi, M Higashiyama, J Maeda, K Oda… - Oncology, 2007 - cir.nii.ac.jp